#496
|
|||
|
|||
|
#497
|
|||
|
|||
Êàê ïðàâèëüíî ïåðåâåñòè Life course epidemiology, the Medical Research Council Life course Epidemiology Unit (MRC LEU)
Ñïàñèáî! |
#498
|
|||
|
|||
Ïðÿìîãî ïåðåâîäà, ïîõîæå, íåò ( òî÷íåå, ÿ åãî íàéòè íå ìîãó), õîòÿ ïîäõîä äîâîëüíî íåíîâûé.
Ìîæåò áûòü, "... îòäåëåíèå ýïèäåìèîëîãèè ôèçè÷åñêèõ è ñîöèàëüíûõ ôàêòîðîâ æèçíåííîãî öèêëà..." (îñíîâûâàÿñü íà îïðåäåëåíèè èç ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ])? Èëè, åñëè óæ íà òî ïîøëî, ïðîñòî "... ýïèäåìèîëîãèè æèçíåííîãî öèêëà"? Âñ¸ ðàâíî â ñêîáêàõ ïðèä¸òñÿ àíãëèéñêèé òåðìèí ïðèâîäèòü. |
#499
|
|||
|
|||
Óñòîÿâøåãîñÿ ïåðåâîäà äëÿ Life course epidemiology íåò, òàê êàê ñàìî ïîíÿòèå â àíãëèéñêîì ÿçûêå ïîÿâèëîñü îòíîñèòåëüíî íåäàâíî. Òàê ÷òî ïðèä¸òñÿ äàâàòü îïèñàòåëüíûé ïåðåâîä, îñíîâûâàÿñü íà îïðåäåëåíèè:
Öèòàòà:
Öèòàòà:
Ìîæåò áûòü, èñïîëüçîâàòü ÷òî-òî âðîäå "ýïèäåìèîëîãèÿ îòäàë¸ííûõ ïîñëåäñòâèé", çäåñü õîòÿ áû ìîæíî ïîíÿòü, ïðî ÷òî áûë îðèãèíàëüíûé òåðìèí. |
#500
|
|||
|
|||
Ìíîãî òåðìèíîâ ïî ãåíåòèêå ïîýòîìó íå î÷åíü ïîíÿòíî. Áóäó áëàãîäàðíà çà ïîìîùü!
Using hybridization probes designed to capture a 6 Mb region flanking CYP21A2, targeted massively parallel sequencing (MPS) was performed to analyze genomic DNA samples from parents and proband to determine parental haplotypes. Plasma DNA from pregnant mothers also underwent targeted MPS to deduce fetal inheritance of parental haplotypes. |
#501
|
|||
|
|||
Íèêòî íå ìîæåò ìíå ïîìî÷ü?(
|
#502
|
||||
|
||||
Öèòàòà:
ÏÑ. Ïðîïóñòèëà ýòîò ïîñò â ñâîå âðåìÿ. |
#503
|
||||
|
||||
Öèòàòà:
|
#504
|
|||
|
|||
|
#505
|
||||
|
||||
Ïîïðîáóþ ïðèãëàñèòü íàøåãî çàìå÷àòåëüíîãî ìîëåêóëÿðíîãî áèîëîãà.
|
#506
|
|||
|
|||
Ìîëåêóëÿðíûé áèîëîã ñ óòðà äî íî÷è íà Ìîëåêóëÿðíîé äèàãíîñòèêå â Êîñìîñå. Âïå÷àòëåíèé ìîðå! Ðåêîìåíäóþ!
Ñìîãó ïîìî÷ü ñ ïåðåâîäîì â ïò. Íàäåþñü, áóäåò åùå àêòóàëüíî )) |
#507
|
|||
|
|||
|
#508
|
|||
|
|||
Ïðèìåðíî òàê:
Äëÿ îïðåäåëåíèÿ ðîäèòåëüñêèõ ãàïëîòèïîâ áûëî ïðîâåäåíî òàðãåòíîå (èëè íàïðàâëåííîå, êàê áîëüøå íðàâèòñÿ) ìàññîâîå ïàðàëëåëüíîå ñåêâåíèðîâàíèå ãåíîìíûõ ÄÍÊ ðîäèòåëåé è ïðîáàíäîâ ñ èñïîëüçîâàíèåì ãèáðèäèçàöèîííûõ çîíäîâ ê îáëàñòè ðàçìåðîì 6 ìåãàáàç, ôëàíêèðóþùåé ãåí CYP21A2. ÄÍÊ ïëàçìû êðîâè áåðåìåííûõ ìàòåðåé òàêæå áûëà ïîäâåðãíóòà íàïðàâëåííîìó ÌÏÑ ñ öåëüþ ïðîñëåäèòü íàñëåäîâàíèå ðîäèòåëüñêèõ ãàïëîòèïîâ ó ïëîäîâ. |
#509
|
|||
|
|||
Öèòàòà:
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
#510
|
|||
|
|||
Äóìàþ, è "öåëåâîå" ïîäîéäåò.
NGS íàñòîëüêî ðåäêî îáñóæäàþò ïî-ðóññêè, ÷òî ìîæíî íå áîÿòüñÿ îøèáèòüñÿ ñî ñëîæèâøèìñÿ òåðìèíîì ) |